Gi and RGS proteins provide biochemical control of androgen receptor nuclear exclusion

Journal of Molecular Neuroscience

Volumn 31, Issue 1, 2007, Pages 1-12

  Rimler, Avi ^a   Jockers, Ralf ^b   Lupowitz, Zipora ^a   Zisapel, Nava ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b INSERM   (France)

Author keywords

Androgen receptor; Calcium; cGMP; Melatonin; Nuclear localization; PKC; RGS10; RGS2; RGS4

Indexed keywords

ANDROGEN RECEPTOR; CALCIUM; CYCLIC GMP; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MELATONIN; PROTEIN KINASE C; RGS PROTEIN; RGS10 PROTEIN; RGS4 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVATION; GENE ACTIVITY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RECEPTOR GENE; REGULATORY MECHANISM;

ANIMALS; CELL LINE; CELL NUCLEUS; CYCLIC GMP; GENES, REPORTER; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; HUMANS; IONOMYCIN; IONOPHORES; MELATONIN; PROTEIN ISOFORMS; RECEPTORS, ANDROGEN; RGS PROTEINS; TETRADECANOYLPHORBOL ACETATE;

EID: 34247172589     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02686113     Document Type: Article

References (29)

1. Benitez-King G. and Anton-Tay F. (1993) Calmodulin mediates melatonin cytoskeletal effects. Experientia 49, 635-641.
2. Berman D. M., Wilkie T. M., and Gilman A. G. (1996) GAIP and RGS-4 are GTPase-activating proteins for the Gi subfamily of G protein alpha subunits. Cell 86, 445-452.
3. Brydon L., Roka F., Petit L., de Coppet P., Tissot M., Barrett P., et al. (1999) Dual signaling of human Mel1a melatonin receptors via G(i2), G(i3), and G(q/11) proteins. Mol. Endocrinol. 13, 2025-2038.
4. Bubis M. and Zisapel N. (1999) Involvement of cGMP in cellular melatonin responses. Biol. Cell 91, 45-49.
5. Burgon P. G., Lee W. L., Nixon A. B., Peralta E. G., and Casey P. J. (2001) Phosphorylation and nuclear translocation of a regulator of G protein signaling RGS10. J. Biol. Chem. 276, 32,828-32,834.
6. Chatterjee T. K. and Fisher R. A. (2000) Cytoplasmic, nuclear, and golgi localization of RGS proteins. Evidence for N-terminal and RGS domain sequences as intracellular targeting motifs. J. Biol. Chem. 275(31), 24,013-24,021.
7. Cunningham M. L., Waldo G. L., Hollinger S., Hepler J. R., and Harden T. K. (2001) Protein kinase C phosphorylates RGS-2 and modulates its capacity for negative regulation of Galpha 11 signaling. J. Biol. Chem. 276, 5438-5444.
8. Dohlman H. G., Song J., Ma D., Courchesne W. E., and Thorner J. (1996) Sst2, a negative regulator of pheromone signaling in the yeast Saccharomyces cerevisiae: expression, localization, and genetic interaction and physical association with Gpa1 (the G-protein alpha subunit) Mol. Cell. Biol. 16, 5194-5209.
9. Druey K. M., Blumer K. J., Kang V. H., and Kehrl J. H. (1996) Inhibition of G-protein-mediated MAP kinase activation by a new mammalian gene family. Nature 379, 742-746.
10. Gilad E., Matzkin H., and Zisapel N. (1997) Inactivation of melatonin receptors by protein kinase C in human prostate epithelial cells. Endocrinology 138, 4255-4261.
11. Gilad E., Laufer M., Matzkin H., and Zisapel N. (1999) Melatonin receptors in PC3 human prostate tumor cells. J. Pineal Res. 26, 211-220.
12. Heximer S. P., Srinivasa S. P., Bernstein L. S., Bernard J. L., Linder M. E., Hepler J. R., and Blumer K. J. (1999) G protein selectivity is a determinant of RGS-2 function. J. Biol. Chem. 274, 34,253-34,259.
13. Hunt T. W., Fields T. A., Casey P. J., and Peralta E. G. (1996) RGS10 is a selective activator of G alpha i GTPase activity. Nature 383, 175-177.
14. Jockers R., Petit L., Lacroix I., de Coppet P., Barrett P., Morgan P. J., et al. (1997) Novel isoforms of Mel1c melatonin receptors modulating intracellular cyclic guanosine 3′,5′-monophosphate levels. Mol. Endocrinol. 11, 1070-1081.
15. Katsuno M., Adachi H., Doyu M., Minamiyama M., Sang C., Kobayashi Y., et al. (2003) Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy. Nat. Med. 9, 768-773.
16. Lissoni P., Cazzaniga M., Tancini G., Scardino E., Musci R., Barni S., et al. (1997) Reversal of clinical resistance to LHRH analogue in metastatic prostate cancer by the pineal hormone melatonin: efficacy of LHRH analogue plus melatonin in patients progressing on LHRH analogue alone. Eur. Urol 31, 178-181.
17. Lupowitz Z., Rimler A., and Zisapel N. (2001) Evaluation of signal transduction pathways mediating the nuclear exclusion of the androgen receptor by melatonin. Cell. Mol. Life Sci. 58, 2129-2135.
18. Orio F., Terouanne B., Georget V., Lumbroso S., Avances C., Siatka C., and Sultan C. (2002) Potential action of IGF-1 and EGF on androgen receptor nuclear transfer and transactivation in normal and cancer human prostate cell lines. Mol. Cell. Endocrinol. 198, 105-114.
19. Reiter R. J. (1998) Melatonin and human reproduction. Ann. Med. 30, 103-108.
20. Reiter R. J., Tan D. X., Manchester L. C., and Qi W. (2001) Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence. Cell. Biochem. Biophys. 34, 237-256.
21. Reppert S. M., Weaver D. R., and Godson C. (1996) Melatonin receptors step into the light: cloning and classification of subtypes. Trends Pharmacol. Sci. 17, 100-102.
22. Rimler A., Culig Z., Levy-Rimler G., Lupowitz Z., Klocker H., Matzkin H., et al. (2001) Melatonin elicits nuclear exclusion of the human androgen receptor and attenuates its activity. Prostate 49, 145-154.
23. Rimler A., Culig Z., Lupowitz Z., and Zisapel N. (2002a) Nuclear exclusion of the androgen receptor by melatonin. J. Steroid Biochem. Mol. Biol. 1696, 1-8.
24. Rimler A., Jockers R., Lupowitz Z., Sampson S. R., and Zisapel N. (2006) Differential effects of melatonin and its downstream effector PKC alpha on subcellular localization of RGS proteins J. Pineal Res. 40, 144-152.
25. Rimler A., Lupowitz Z., and Zisapel N. (2002b) Differential regulation by melatonin of cell growth and androgen receptor binding to the androgen response element in prostate cancer cells. Neuroendocrinol. Lett. 23(Suppl. 11), 45-49.
26. Roy A. K., Tyagi R. K., Song C. S., Lavrovsky Y., Ahn S. C., Oh T. S., and Chatterjee B. (2001) Androgen receptor: structural domains and functional dynamics after ligand-receptor interaction. Ann. N. Y. Acad. Sci. 949, 44-57.
27. Siu S. W., Lau K. W., Tam P. C., and Shiu S. Y. (2002) Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity. Prostate 52, 106-122.
28. Watson N., Linder M. E., Druey K. M., Kehrl J. H., and Blumer K. J. (1996) RGS family members: GTPase-activating proteins for heterotrimeric G-protein alpha-subunits. Nature 383, 172-175.
29. Witt-Enderby P. A., Jarzynka M. J., Krawitt B. J., and Melan M. A. (2004) Knock-down of RGS4 and beta tubulin in CHO cells expressing the human MT1 melatonin receptor prevents melatonin-induced receptor desensitization. Life Sci. 75, 2703-2715.